Extensive bone marrow necrosis associated with antiphospholipid antibodies

      This paper is only available as a PDF. To read, Please Download here.
      Bone marrow necrosis (BMN), defined morphologically by destruction of hematopoietic tissue, including the stroma, with preservation of the bone, is a rare syndrome. The conditions in which it is seen include sickle cell disease, acute leukemia, metastatic neoplasia, and bacterial infection, particularly when hypovolemia and septic shock are present. BMN is also associated with disseminated intravascular coagulation (DIC) following irradiation and antineoplastic therapy. The antiphospolipid syndrome (APS) is characterized by antibodies directed against the antiphospolipid substrate. Because this substrate is prominently involved in the coagulation cascade and widely distributed on cell walls, patients present with venous or arterial thromboses, recurrent abortion, thrombocytopenia, and Coombs' positive hemolytic anemia, typically with raised anticardiolipin antibodies or a diagnostic lupus anticoagulant test. BMN does not appear to have been previously recognized in this context. We report what we believe to be the first such case and suggest that the high titers of antibodies present may have played a central role in its pathogenesis.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Kiraly JF
        • Wheby MS
        Bone marrow necrosis.
        Am J Med. 1976; 60: 361-368
        • Brown CH
        Bone marrow necrosis. A study of seventy cases.
        Johns Hopkins Med J. 1972; 131: 189-203
        • Asherson RA
        A “primary” antiphospholipid syndrome?.
        J Rheumatol. 1988; 15: 1741-1745
        • Hunt FA
        • Rylaff DB
        • Hart RA
        • Bundersen PG
        Serum cross-linked fibrin (XDP) and fibrinogen degradation products (FDP) in disorders associated with activ-ation of the coagulation or fibrinolytic systems.
        Br J Haematol. 1985; 60: 715-722
        • Tan EM
        • Cohen AS
        • Fries JF
        • et al.
        Revised criteria for the classification of systemic lupus erythematosus.
        Arthritis Rheum. 1982; 25: 1271-1277
        • Creagh MD
        • Greaves M
        Lupus anticoagulant.
        Blood Rev. 1991; 5: 162-167
        • Schick PK
        • Kurica KB
        • Chacko GH
        Location of phosphatidylethanolamine and phosphatidylserine in the human platelet plasma membrane.
        J Clin Invest. 1976; 57: 1221-1226
        • Alarcon-Segovia D
        • Sanchez-Guerrero J
        Primary antiphospholipid syndrome.
        J Rheumatol. 1989; 16: 482-488
        • Out HJ
        • De Groot PG
        • Van Vliet M
        • et al.
        Antibodies to platelets in patients with anti-phospholipid antibodies.
        Blood. 1991; 77: 2655-2659
        • Deleze M
        • Alarcon-Segovia DA
        • Oria CV
        • et al.
        Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies.
        J Rheumatol. 1989; 16: 926-930
        • Rose MS
        Apparent necrosis of bone-marrow in a patient with disseminated intravascular coagulation, post partum.
        Lancet. 1973; 2: 730-731
        • Knickerbocker WJ
        • Quenville NF
        Widespread marrow necrosis during pregnancy.
        Skeletal Radiol. 1982; 9: 37-40
        • Laso F
        • Gonzalez-Diaz M
        • Paz J-I
        • De Castro S
        Bone marrow necrosis associated with tumor emboli and disseminated intravascular coagulation.
        Arch Intern Med. 1983; 143: Letter
        • Nachamie BA
        • Dorfman HD
        Ischemic necrosis of bone in sickle cell trait.
        Mt Sinai J Med. (NY). 1974; 41: 527-536
        • Triplett DA
        Laboratory diagnosis of lupus anticoagulants.
        in: Semin Thromb Hemost. 16. 1990: 182-189